qwertyuiopasdfghjklzxcvbnmqwerty

uiopasdfghjklzxcvbnmqwertyuiopasd
fghjklzxcvbnmqwertyuiopasdfghjklzx
cvbnmqwertyuiopasdfghjklzxcvbnmq
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
hjklzxcvbnmqwertyuiopasdfghjklzxc
vbnmqwertyuiopasdfghjklzxcvbnmq
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
NIFTY OUTLOOK
hjklzxcvbnmqwertyuiopasdfghjklzxc
REPORT
vbnmqwertyuiopasdfghjklzxcvbnmq
th
26 May 2017
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
hjklzxcvbnmrtyuiopasdfghjklzxcvbn
mqwertyuiopasdfghjklzxcvbnmqwert
yuiopasdfghjklzxcvbnmqwertyuiopas
 26th May 2017

NIFTY

NIFTY SPOT : R1:9539 R2:9580 R3:9600

PIVOT : 9463 S1:9419 S2:9343 S3:9300

NIFTY DAILY CHART

NIFTY OUTLOOK
Nifty is likely to open in a negative note. After a unexpected bull rally on expiry nifty has surprised everyone.
Momentum indicator RSI is indicating over bought zone for nifty. We are expecting nifty to show some
correction from this level. For positional traders it is advised to create fresh shorts round 9525 with a small stop
loss of 9575 for the target of 9350.Intraday traders are advised to adopt buy on dips strategy for the session.

Strategy: long nifty around 9450 for the target of 9500 with stop loss of 9410

Name Current Value Change % Chg Open High Low

FTSE 100 (May 25) 7,517.71 2.81 0.04 7,514.90 7,529.74 7,497.07
CAC 40 (May 25) 5,337.16 -4.18 -0.08 5,360.97 5,366.70 5,323.11
DAX (May 25) 12,621.72 -21.15 -0.17 12,693.84 12,697.66 12,543.77
Nikkei 225 (May
19,735.32 -77.81 -0.39 19,798.49 19,801.59 19,735.32
26)
Straits Times (May
3,227.29 -7.08 -0.22 3,227.38 3,229.66 3,219.27
26)
Hang Seng (May
25,649.67 18.89 0.07 25,670.98 25,724.40 25,588.70
26)

Taiwan Weighted 10,078.29 -30.2 -0.3 10,090.18 10,121.88 10,073.19

(May 26)
SGX Nifty (May
9,486.00 -10 -0.11 9,505.50 9,518.50 9,472.00
26)

WWW.EQUITYRESEARCHLAB.COM
 26th May 2017

CORPORATE
Results Today:NEWS
ITC, Sun Pharma, DLF, HPCL, 3M India, Divis Laboratories, Tech Mahindra,
ONGC, SUN TV, Crompton Greaves Consumer Electricals, CG Power And Industrial Solutions,
Indoco Remedies, NBCC (India), Tata Chemicals, Torrent Pharmaceuticals, Mahanagar Gas, Alkem
Laboratories, Eros International Media, Indian Hotels, Maharashtra Seamless, OMDC, Sudarshan
Chemical, Sunteck Realty, Trent, Gujarat Alkalies Chemicals, Gujarat State Financial Corporation,
Arman Financial Services, Asahi Songwon Colors, Asian Hotels (West), Associated Alcohols
Breweries, Allied Digital Services, Borax Morarji, Eros International Media, Excel Industries, FDC,
Finolex Industries, Geojit Financial Services, Hind Rectifiers, IFB Industries, Jindal Drilling
Industries, Kakatiya Cement Sugar Industries, Kamat Hotels, Kwality, Maharashtra Seamless,
Mandhana Industries, Manugraph India, Satin Creditcare Network

Tata Power
Issuance of non-convertible debentures of Rs 500 crore

IDBI Bank
CARE revises rating to CARE A negative of Lower tier II bond amounting to 50cr
Crafts Comprehensive Turnaround strategy; takes steps to shore up capital

Infosys
Announces strategic alliance with HP Inc. to Accelerate Digital Transformation for the Enterprise

Glenmark Pharma
S&P Global Ratings has reaffirmed our credit rating as BB

NALCO
Inks MOU with Government of India setting Higher Targets in production

Fortune Financial
Board has approved raising of equity capital up to Rs. 400 crore, through private placement, QIP
IT stocks (Infosys, TCS, Tech Mahondra)
Cognizant says not planning layoffs

Dr Reddys
SEZ unit completes USFDA inspection for second time

IDBI Bank
Bank plans to raise more money as part of its turnaround plan

WWW.EQUITYRESEARCHLAB.COM
 26th May 2017

ERL RESEARCH TEAM

Member Name Designation E-mail ID

Mr. Tuhinanshu Jain Research Head Tuhinanshu.jain@equityresearchlab.co.in
Mr. Manish Bimal Sr. Research Analyst Manish.bimal@equityresearchlab.co.in

DISCLAIMER

The information and views in this report, our website & all the service we provide are believed to be
reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have
the right to choose the product/s that suits them the most. Investment in Stocks has its own risks.
Sincere efforts have been made to present the right investment perspective. The information contained
herein is based on analysis and up on sources that we consider reliable. We, however, do not vouch
for the accuracy or the completeness thereof. This material is for personal information and we are not
responsible for any loss incurred based upon it & takes no responsibility whatsoever for any financial
profit s or loss which may arise from the recommendations above. The stock price projections shown
are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice.

Equity Research Lab does not purport to be an invitation or an offer to buy or sell any financial
instrument. Analyst or any person related to Equity Research Lab might be holding positions in the
stocks recommended. It is understood that anyone who is browsing through the site has done so at his
free will and does not read any views expressed as a recommendation for which either the site or its
owners or anyone can be held responsible for. Any surfing and reading of the information is the
acceptance of this disclaimer.

Our Clients (Paid or Unpaid), any third party or anyone else have no rights to forward or share our
calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly
or indirectly by them. If found so then Serious Legal Actions can be taken. Any surfing and reading of
the information is the acceptance of this disclaimer.

ALL RIGHTS RESERVED.

WWW.EQUITYRESEARCHLAB.COM